These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34220816)

  • 1. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
    Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
    Front Immunol; 2021; 12():669812. PubMed ID: 34220816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.
    Omoniyi AA; Adebisi SS; Musa SA; Nzalak JO; Bauchi ZM; Bako KW; Olatomide OD; Zachariah R; Nyengaard JR
    Sci Rep; 2022 May; 12(1):8736. PubMed ID: 35610299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever.
    Alam R; Samad A; Ahammad F; Nur SM; Alsaiari AA; Imon RR; Talukder MEK; Nain Z; Rahman MM; Mohammad F; Karpiński TM
    BMC Med; 2023 Feb; 21(1):36. PubMed ID: 36726141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach.
    Nosrati M; Behbahani M; Mohabatkar H
    J Biomed Inform; 2019 May; 93():103160. PubMed ID: 30928513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus.
    Khan MSA; Nain Z; Syed SB; Abdulla F; Moni MA; Sheam MM; Karim MM; Adhikari UK
    Mol Cell Probes; 2021 Feb; 55():101693. PubMed ID: 33388416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
    Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
    Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens.
    Nosrati M; Mohabatkar H; Behbahani M
    Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of functional epitopes of structural proteins and in-silico designing of dual acting multiepitope anti-tick vaccine against emerging Crimean-Congo hemorrhagic fever virus.
    Shrivastava N; Verma A; Dash PK
    Eur J Pharm Sci; 2020 Aug; 151():105396. PubMed ID: 32479862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
    Zivcec M; Safronetz D; Scott DP; Robertson S; Feldmann H
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006628. PubMed ID: 30011277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.
    Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R
    Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Multi-epitope Based Subunit Vaccine Against Crimean-Congo Hemorrhagic Fever Virus Using Reverse Vaccinology Approach.
    Imran MA; Islam MR; Saha A; Ferdousee S; Mishu MA; Ghosh A
    Int J Pept Res Ther; 2022; 28(4):124. PubMed ID: 35789799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
    Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model.
    Hawman DW; Ahlén G; Appelberg KS; Meade-White K; Hanley PW; Scott D; Monteil V; Devignot S; Okumura A; Weber F; Feldmann H; Sällberg M; Mirazimi A
    Nat Microbiol; 2021 Feb; 6(2):187-195. PubMed ID: 33257849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1.
    Hu YL; Zhang LQ; Liu XQ; Ye W; Zhao YX; Zhang L; Qiang ZX; Zhang LX; Lei YF; Jiang DB; Cheng LF; Zhang FL
    Front Cell Infect Microbiol; 2023; 13():1121163. PubMed ID: 37026060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean-Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target.
    Shah SZ; Jabbar B; Mirza MU; Waqas M; Aziz S; Halim SA; Ali A; Rafique S; Idrees M; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
    Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
    BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.